Global Next-generation Sequencing Market, By Product (Consumables, Platforms and Services), By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Single Molecule Real Time Sequencing and Other Technologies), By End User (Academic & Clinical Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics and Others), By Application (Biomarkers & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Agriculture & Animal Research and Other Applications), By Region, Competition, Forecast & Opportunities, 2025

December 2020 | 153 pages | ID: GAB8DC0CC0B0EN
TechSci Research

Abstracts

Global next-generation sequencing market was valued at USD 8206.75 Million in 2019 and is projected to grow at a CAGR of 19.59% during the forecast period. Enhancing regulatory framework for next-generation sequencing based tests for diagnostics is the key factor for the growth of global next-generation sequencing market during the forecast period. Moreover, advancements in next-generation sequencing coupled with reduction in the price of NGS platforms are some other major factors that are anticipated to bolster the growth of global next-generation sequencing market over the coming years. However, some of the factors that might act as major impediments to the growth of global next-generation sequencing market includes concerns pertaining to the standards of NGS based diagnostics.

The global next-generation sequencing market is segmented based on product, technology, end user, application, region and company. Based on technology, the market can be segmented into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, single molecule real time sequencing and other technologies. Among them, the sequencing by synthesis (SBS) segment dominated the market until 2019 with share of 73.04% and is projected to grow with a healthy CAGR over the forecast period due to development of new and advanced NGS platforms along with rising demand for Illumina’s systems as it uses the SBS technology.

Major players operating in the global next-generation sequencing market include Illumina, Inc., Thermo Fisher Scientific, Inc, BGI Group, Perkinelmer Inc., Agilent Technologies, Inc., Pacific Biosciences of California Inc., F. Hoffmann-La Roche Ltd., 10x Genomics Inc., Amgen Inc., Takara Bio Inc. and others.

Years considered for this report:

• Historical Years: 2015-2018
• Base Year: 2019
• Estimated Year: 2020
• Forecast Period: 2021–2025

Objective of the Study:

• To analyse and forecast the market size of global next-generation sequencing market.
• To classify and forecast global next-generation sequencing market based on product, technology, end user, application, company and regional distribution.
• To identify drivers and challenges for global next-generation sequencing market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global next-generation sequencing market.
• To conduct pricing analysis for global next-generation sequencing market.
• To identify and analyse the profile of leading players operating in global next-generation sequencing market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of service providers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the service providers which could not be identified due to the limitations of secondary research. TechSci Research analyzed new services, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global next-generation sequencing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

• Next-generation sequencing service providers, vendors and other stakeholders
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to next-generation sequencing
• Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, vendors and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global next-generation sequencing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• Market, By Product:
• Consumables
• Platforms
• Services
• Market, By Technology:
• Sequencing by Synthesis
• Ion Semiconductor Sequencing
• Sequencing by Ligation
• Single Molecule Real Time Sequencing
• Other Technologies
• Market, By End User:
• Academic & Clinical Research Centers
• Pharmaceutical & Biotechnology Companies
• Hospitals & Clinics
• Others
• Market, By Application:
• Biomarkers & Cancer
• Diagnostics
• Reproductive Health
• Personalized Medicine
• Agriculture & Animal Research
• Other Applications
• Market, By Region:
• North America
• United States
• Mexico
• Canada
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia
• Middle East & Africa
• South Africa
• UAE
• Saudi Arabia
• South America
• Brazil
• Argentina
• Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global next-generation sequencing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

2. RESEARCH METHODOLOGY

3. IMPACT OF COVID-19 ON GLOBAL NEXT-GENERATION SEQUENCING (NGS) MARKET

4. EXECUTIVE SUMMARY

5. VOICE OF CUSTOMER

5.1. By Brand Recall
5.2. By Preferred Technology
5.3. By Preferred Application

6. GLOBAL NEXT-GENERATION SEQUENCING (NGS) MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Product (Consumables, Platforms and Services)
    6.2.1.1. By Consumables (Sample preparation consumables and Other Consumables)
    6.2.1.2. By Platforms (HiSeq series, MiSeq series, ION Torrent, SOLiD, Pacbio Rs II and Sequel system, Other Sequencing Platforms)
    6.2.1.3. By Services (Sequencing Services and Data management services)
  6.2.2. By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Single Molecule Real Time Sequencing and Other)
  6.2.3. By End User (Academic & Clinical Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics and Others)
  6.2.4. By Application (Biomarkers & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Agriculture & Animal Research and Others)
  6.2.5. By Region
  6.2.6. By Company (2019)
6.3. Product Market Map

7. NORTH AMERICA NEXT-GENERATION SEQUENCING (NGS) MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Product
  7.2.2. By Technology
  7.2.3. By End User
  7.2.4. By Application
  7.2.5. By Country (United States; Canada; Mexico and Rest of North America)
7.3. North America: Country Analysis
  7.3.1. United States Next-Generation Sequencing (NGS) Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Product
      7.3.1.2.2. By Technology
      7.3.1.2.3. By Application
  7.3.2. Canada Next-Generation Sequencing (NGS) Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Product
      7.3.2.2.2. By Technology
      7.3.2.2.3. By Application
  7.3.3. Mexico Next-Generation Sequencing (NGS) Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Product
      7.3.3.2.2. By Technology
      7.3.3.2.3. By Application

8. EUROPE NEXT-GENERATION SEQUENCING (NGS) MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Product
  8.2.2. By Technology
  8.2.3. By End User
  8.2.4. By Application
  8.2.5. By Country (France; Germany; UK; Italy; Spain and Rest of Europe)
8.3. Europe: Country Analysis
  8.3.1. France Next-Generation Sequencing (NGS) Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Product
      8.3.1.2.2. By Technology
      8.3.1.2.3. By Application
  8.3.2. Germany Next-Generation Sequencing (NGS) Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Product
      8.3.2.2.2. By Technology
      8.3.2.2.3. By Application
  8.3.3. United Kingdom Next-Generation Sequencing (NGS) Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Product
      8.3.3.2.2. By Technology
      8.3.3.2.3. By Application
  8.3.4. Italy Next-Generation Sequencing (NGS) Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Product
      8.3.4.2.2. By Technology
      8.3.4.2.3. By Application
  8.3.5. Spain Next-Generation Sequencing (NGS) Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Product
      8.3.5.2.2. By Technology
      8.3.5.2.3. By Application

9. ASIA-PACIFIC NEXT-GENERATION SEQUENCING (NGS) MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Product
  9.2.2. By Technology
  9.2.3. By End User
  9.2.4. By Application
  9.2.5. By Country (China; India; Japan; South Korea; Australia; and Rest of Asia Pacific)
9.3. Asia-Pacific: Country Analysis
  9.3.1. China Next-Generation Sequencing (NGS) Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Product
      9.3.1.2.2. By Technology
      9.3.1.2.3. By Application
  9.3.2. India Next-Generation Sequencing (NGS) Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Product
      9.3.2.2.2. By Technology
      9.3.2.2.3. By Application
  9.3.3. Japan Next-Generation Sequencing (NGS) Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Product
      9.3.3.2.2. By Technology
      9.3.3.2.3. By Application
  9.3.4. South Korea Next-Generation Sequencing (NGS) Market Outlook
    9.3.4.1. Market Size & Forecast
      9.3.4.1.1. By Value
    9.3.4.2. Market Share & Forecast
      9.3.4.2.1. By Product
      9.3.4.2.2. By Technology
      9.3.4.2.3. By Application
  9.3.5. Australia Next-Generation Sequencing (NGS) Market Outlook
    9.3.5.1. Market Size & Forecast
      9.3.5.1.1. By Value
    9.3.5.2. Market Share & Forecast
      9.3.5.2.1. By Product
      9.3.5.2.2. By Technology
      9.3.5.2.3. By Application

10. MIDDLE EAST AND AFRICA NEXT-GENERATION SEQUENCING (NGS) MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Product
  10.2.2. By Technology
  10.2.3. By End User
  10.2.4. By Application
  10.2.5. By Country (UAE; Saudi Arabia; South Africa and Rest of Middle East & Africa)
10.3. MEA: Country Analysis
  10.3.1. South Africa Next-Generation Sequencing (NGS) Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Product
      10.3.1.2.2. By Technology
      10.3.1.2.3. By Application
  10.3.2. Saudi Arabia Next-Generation Sequencing (NGS) Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Product
      10.3.2.2.2. By Technology
      10.3.2.2.3. By Application
  10.3.3. UAE Next-Generation Sequencing (NGS) Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Product
      10.3.3.2.2. By Technology
      10.3.3.2.3. By Application

11. SOUTH AMERICA NEXT-GENERATION SEQUENCING (NGS) MARKET OUTLOOK

11.1. Market Size & Forecast
  11.1.1. By Value
11.2. Market Share & Forecast
  11.2.1. By Product
  11.2.2. By Technology
  11.2.3. By End User
  11.2.4. By Application
  11.2.5. By Country (Brazil; Argentina; Colombia; and Rest of South America)
11.3. South America: Country Analysis
  11.3.1. Brazil Next-Generation Sequencing (NGS) Market Outlook
    11.3.1.1. Market Size & Forecast
      11.3.1.1.1. By Value
    11.3.1.2. Market Share & Forecast
      11.3.1.2.1. By Product
      11.3.1.2.2. By Technology
      11.3.1.2.3. By Application
  11.3.2. Argentina Next-Generation Sequencing (NGS) Market Outlook
    11.3.2.1. Market Size & Forecast
      11.3.2.1.1. By Value
    11.3.2.2. Market Share & Forecast
      11.3.2.2.1. By Product
      11.3.2.2.2. By Technology
      11.3.2.2.3. By Application
  11.3.3. Colombia Next-Generation Sequencing (NGS) Market Outlook
    11.3.3.1. Market Size & Forecast
      11.3.3.1.1. By Value
    11.3.3.2. Market Share & Forecast
      11.3.3.2.1. By Product
      11.3.3.2.2. By Technology
      11.3.3.2.3. By Application

12. MARKET DYNAMICS

12.1. Drivers
12.2. Challenges

13. MARKET TRENDS & DEVELOPMENTS

14. COMPETITIVE LANDSCAPE (NGS PLATFORM PROVIDERS)

14.1. Competition Outlook
14.2. Company Profiles
  14.2.1. Illumina, Inc.
  14.2.2. Thermo Fisher Scientific, Inc
  14.2.3. BGI Group
  14.2.4. Perkinelmer Inc.
  14.2.5. Agilent Technologies, Inc.
  14.2.6. Pacific Biosciences of California Inc.
  14.2.7. F. Hoffmann-La Roche Ltd.
  14.2.8. 10x Genomics Inc.
  14.2.9. Amgen Inc.
  14.2.10. Takara Bio Inc.

15. STRATEGIC RECOMMENDATIONS

16. ABOUT US & DISCLAIMER

(Note: The companies list can be customized based on the client requirements.)

List Of Figures

LIST OF FIGURES

Figure 1: Global Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
Figure 2: Global Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
Figure 3:

Global Next-Generation Sequencing Market Share, By Product, By Consumables, By Value,
2015-2025F
Figure 4: Global Next-Generation Sequencing Market Share, By Product, By Platforms, By Value, 2015-2025F
Figure 5: Global Next-Generation Sequencing Market Share, By Product, By Services, By Value, 2015-2025F
Figure 6: Global Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
Figure 7: Global Next-Generation Sequencing Market Share, By End User, By Value, 2015-2025F
Figure 8: Global Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
Figure 9: Global Next-Generation Sequencing Market Share, By Company, By Value, 2019
Figure 10: Global Next-Generation Sequencing Market Share, By Region, By Value, 2019 & 2025F
Figure 11:

Global Next-Generation Sequencing Market Map, By Product - Market Size (USD Million) & Growth
Rate (%)
Figure 12:

Global Next-Generation Sequencing Market Map, By Technology - Market Size (USD Million) &
Growth Rate (%)
Figure 13:

Global Next-Generation Sequencing Market Map, By End User - Market Size (USD Million) & Growth
Rate (%)
Figure 14:

Global Next-Generation Sequencing Market Map, By Application - Market Size (USD Million) &
Growth Rate (%)
Figure 15:

Global Next-Generation Sequencing Market Map, By Region - Market Size (USD Million) & Growth
Rate (%)
Figure 16:
North America Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
Figure 17:
North America Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
Figure 18: North America Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
Figure 19: North America Next-Generation Sequencing Market Share, By End User, By Value, 2015-2025F
Figure 20: North America Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
Figure 21: North America Next-Generation Sequencing Market Share, By Region, By Value, 2015-2025F
Figure 22: United States Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
Figure 23:

Total Human Genome Funding by National Institute for Health (NIH) in United States, USD Million,
2015-2019
Figure 24: United States Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
Figure 25: United States Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
Figure 26: United States Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
Figure 27: Canada Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
Figure 28: Canada Hospital Establishments, By Region, 2019 (Units)
Figure 29: Canada Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
Figure 30: Canada Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
Figure 31: Canada Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
Figure 32: Mexico Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
Figure 33: Mexico Healthcare Spending, By Value, 2015 -2019 (USD Per Capita)
Figure 34: Mexico Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
Figure 35: Mexico Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
Figure 36: Mexico Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
Figure 37: Europe Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
Figure 38: Europe Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
Figure 39: Europe Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
Figure 40: Europe Next-Generation Sequencing Market Share, By End User, By Value, 2015-2025F
Figure 41: Europe Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
Figure 42: Europe Next-Generation Sequencing Market Share, By Region, By Value, 2015-2025F
Figure 43: United Kingdom Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
Figure 44: New Cancer Cases in United Kingdom (%), 2019
Figure 45: United Kingdom Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
Figure 46: United Kingdom Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
Figure 47: United Kingdom Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
Figure 48: Germany Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
Figure 49: New Cancer Cases in Germany (%), Females, All Ages, 2019
Figure 50: Germany Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
Figure 51: Germany Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
Figure 52: Germany Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
Figure 53: France Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
Figure 54: France Healthcare Spending, By Value (USD Per Capita), 2015-2019
Figure 55: France Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
Figure 56: France Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
Figure 57: France Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
Figure 58: Italy Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
Figure 59: New Cancer Cases in Italy (%), Males, All Ages, 2019
Figure 60: Italy Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
Figure 61: Italy Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
Figure 62: Italy Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
Figure 63: Spain Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
Figure 64: Number of New Cancer Cases in Spain, By Cancer Site, 2019
Figure 65: Spain Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
Figure 66: Spain Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
Figure 67: Spain Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
Figure 68: Asia-Pacific Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
Figure 69: Asia-Pacific Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
Figure 70: Asia-Pacific Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
Figure 71: Asia-Pacific Next-Generation Sequencing Market Share, By End User, By Value, 2015-2025F
Figure 72: Asia-Pacific Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
Figure 73: Asia-Pacific Next-Generation Sequencing Market Share, By Region, By Value, 2015-2025F
Figure 74: China Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
Figure 75: New Cancer Cases in China (%), 2019
Figure 76: China Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
Figure 77: China Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
Figure 78: China Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
Figure 79: Japan Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
Figure 80: Japan Total Health Expenditure as a Share of GDP (%), 2015 - 2019
Figure 81: Japan Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
Figure 82: Japan Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
Figure 83: Japan Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
Figure 84: South Korea Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
Figure 85: New Cancer Cases in South Korea (%), 2019
Figure 86: South Korea Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
Figure 87: South Korea Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
Figure 88: South Korea Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
Figure 89: Australia Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
Figure 90: % of Public and Private Hospitals in Australia, 2019
Figure 91: Australia Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
Figure 92: Australia Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
Figure 93: Australia Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
Figure 94: India Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
Figure 95: New Cancer Cases in India (%), Both Sexes, All Ages, 2019
Figure 96: India Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
Figure 97: India Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
Figure 98: India Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
Figure 99: South America Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
Figure 100: South America Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
Figure 101: South America Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
Figure 102: South America Next-Generation Sequencing Market Share, By End User, By Value, 2015-2025F
Figure 103: South America Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
Figure 104: South America Next-Generation Sequencing Market Share, By Region, By Value, 2015-2025F
Figure 105: Brazil Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
Figure 106: Total Number of Hospitals in Brazil, 2015-2018
Figure 107: Brazil Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
Figure 108: Brazil Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
Figure 109: Brazil Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
Figure 110: Argentina Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
Figure 111: Argentina Health Expenditure (% of GDP), 2015-2019
Figure 112: Argentina Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
Figure 113: Argentina Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
Figure 114: Argentina Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
Figure 115: Colombia Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
Figure 116: New Cancer Cases in Colombia (%), 2019
Figure 117: Colombia Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
Figure 118: Colombia Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
Figure 119: Colombia Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
Figure 120:
Middle East and Africa Next-Generation Sequencing Market Size, By Value, 2015-2025F
(USD Million)
Figure 121:
Middle East and Africa Next-Generation Sequencing Market Share, By Product, By Value,
2015-2025F
Figure 122:
Middle East and Africa Next-Generation Sequencing Market Share, By Technology, By Value,
2015-2025F
Figure 123: Middle East and Africa Next-Generation Sequencing Market Share, By End User, By Value,
2015-2025F
Figure 124: Middle East and Africa Next-Generation Sequencing Market Share, By Application, By Value,
2015-2025F
Figure 125:
Middle East and Africa Next-Generation Sequencing Market Share, By Region, By Value,
2015-2025F
Figure 126: UAE Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
Figure 127: UAE Health Expenditure (% of GDP), 2015-2019
Figure 128: UAE Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
Figure 129: UAE Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
Figure 130: UAE Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
Figure 131: Saudi Arabia Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
Figure 132: Total Number of Hospitals in Saudi Arabia, 2015-2019
Figure 133: Saudi Arabia Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
Figure 134: Saudi Arabia Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
Figure 135: Saudi Arabia Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
Figure 136: South Africa Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
Figure 137: South Africa Healthcare Spending, By Value, 2015 -2019 (USD Per Capita)
Figure 138: South Africa Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
Figure 139: South Africa Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
Figure 140: South Africa Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F

COMPANIES MENTIONED

1. Illumina, Inc.
2. Thermo Fisher Scientific, Inc
3. BGI Group
4. Perkinelmer Inc.
5. Agilent Technologies, Inc.
6. Pacific Biosciences of California Inc.
7. F. Hoffmann-La Roche Ltd.
8. 10x Genomics Inc.
9. Amgen Inc.
10. Takara Bio Inc.